Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Rosuvastatin 40 mg tablet
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹418/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Rosumore 40 Tablet contains Rosuvastatin 40 mg, a high-intensity statin belonging to the HMG-CoA reductase inhibitor class. It is used for the aggressive management of lipid disorders and for significantly reducing cardiovascular risk in patients with high or very high cholesterol levels. Rosuvastatin works by blocking the enzyme responsible for cholesterol production in the liver, leading to a substantial reduction in low-density lipoprotein cholesterol (LDL-C), total cholesterol, and triglycerides, while increasing levels of high-density lipoprotein cholesterol (HDL-C). The 40 mg strength is typically prescribed to patients who fail to achieve target lipid levels on lower doses or those at high risk of cardiovascular events due to pre-existing conditions like diabetes, coronary artery disease, or a history of myocardial infarction or stroke. Rosumore 40 also helps stabilize atherosclerotic plaques and reduce vascular inflammation, thereby lowering the risk of future cardiac events. It is a once-daily oral formulation known for its potent efficacy and long half-life, which enhances patient adherence.
Rosumore 40 is generally well tolerated, but some patients may experience side effects such as headache, dizziness, abdominal pain, constipation, nausea, or muscle aches. At higher doses like 40 mg, the risk of myopathy, rhabdomyolysis, or liver enzyme elevation increases slightly, especially in elderly patients or those with renal impairment. Patients should report any unexplained muscle pain, weakness, or fatigue. Routine monitoring of liver function tests (LFTs) and creatine kinase (CK) levels may be advised during treatment.
Rosumore 40 Tablet is indicated for the treatment of primary hyperlipidemia, mixed dyslipidemia, and homozygous familial hypercholesterolemia. It is also recommended for the primary and secondary prevention of major cardiovascular events in high-risk individuals who require intensive lipid-lowering therapy.
Rosumore 40 should only be taken under the supervision of a qualified healthcare provider. It is contraindicated in pregnancy and lactation, as statins can cause harm to the fetus. The tablet is also contraindicated in patients with active liver disease, unexplained persistent elevations in liver enzymes, or known hypersensitivity to Rosuvastatin. Alcohol consumption should be minimized to avoid additional liver stress. Patients should continue following a cholesterol-lowering diet and engage in regular exercise. Periodic lipid profile and liver function monitoring is essential for long-term safety and effectiveness.
Store in a cool, dry place at a temperature not exceeding 30°C. Protect the tablets from direct sunlight and moisture. Keep out of reach of children and do not consume the tablet after the expiry date mentioned on the packaging.
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75mg + Rosuvastatin 20mg + Clopidogrel 150mg Tablet
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
Composition : Rosuvastatin 10mg + Clopidogrel 75mg Capsule
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
Composition : Rosuvastatin (5mg) tablet
Composition : Rosuvastatin 40 mg tablet
Composition : Rosuvastatin 20 mg + Ezetimibe 10 mg tablet
Composition : Rosuvastatin 10 mg + Ezetimibe 10 mg tablet
Composition : Rosuvastatin 10 mg tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Rosuvastatin 40 mg Tablet is a high-potency statin-class lipid-lowering medicine used for the management of severe hypercholesterolemia, mixed dyslipidemia, and prevention of major cardiovascular events such as heart attack and stroke in high-risk patients. It works by significantly reducing LDL cholesterol and improving lipid profiles, making it a widely prescribed cardiovascular and chronic care segment product. Its strong demand among cardiologists and physicians makes it a valuable addition to the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from the consistent demand for advanced cholesterol management therapies. Rosuvastatin 40 mg is frequently prescribed for patients requiring intensive lipid-lowering treatment, ensuring regular repeat prescriptions, stable sales volumes, and continuous market demand across retail and hospital channels.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities in the cardiovascular and lipid-lowering segment, including Rosuvastatin 40 mg Tablet. We provide monopoly rights, quality-focused manufacturing, attractive business support, and dependable product availability to help franchise partners expand their presence in the cardiac care market.
Wholesalers and stockists benefit from strong prescription-driven demand, long-term patient usage, and widespread acceptance among cardiac specialists. Since lipid-lowering therapy is often required for extended periods, this product offers steady product movement, recurring business opportunities, and sustainable growth potential in pharmaceutical distribution.
Medical distributors, stockists, and pharma professionals interested in cardiovascular and cholesterol-management products can contact Cafoli Lifecare to discuss pricing, product availability, monopoly franchise rights, and business opportunities. We provide comprehensive support through marketing materials, reliable supply chains, and territory-based franchise assistance to help partners grow successfully.